Lead idea
Eli Lilly's non-cyclical AI cash cow
The bull case made for Eli Lilly was its combination of a non-cyclical, government-funded healthcare cash cow and aggressive AI investments in drug discovery. Jordi Visser (veteran macro investor and author of the VisserLabs Substack) made the case on The Pomp Podcast’s “Bitcoin Survives Biggest Crypto Hack In History?!”, aired 31 October 2026. The reasoning rested on 40% revenue growth, massive beats, and raised guidance driven by GLP-1 drugs, with only ~10% US penetration.